venetoclax,azacitidine
abbvie,roche
['toci', 'aza ', 'leusm', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'viale-a', '+aza', 'abbvie']
#ash22 #leusm long term fu of viale-a study. median os for patients with mrd &lt;10-3 who had achieved cr+cri was 34.2 mo, and median os for pts with idh1/2m was 19.9 mo. later in the course 5 weekly schedule is more practical! 
Assistant Professor @MayoCancerCare @MayoClinic Alumni @MDAndersonNews. Interest in Acute Leukemia and Chronic myeloid disorders. Views are my own